
|Articles|November 1, 2003
Understanding Hair Development
Chicago - New findings from ongoing research aiming to delineate the mechanism of action of eflornithine hydrochloride 13.9 percent cream (Vaniqa) in the treatment of pseudofolliculitis barbae (PFB) indicate that one pathway may involve drug-induced actin disarray in the outer root sheath with a subsequent effect on axial fiber development, said Steve Chow, M.S., to attendees at Ethnic Hair and Skin: New Directions in Research.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
3
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
4
Dermatology Conferences and Meetings Calendar: December 2025
5


















